Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Affect of Hemostasis With Bipolar Coagulation Versus SURGIFLO Placement on Ovarian Reserve and Future Fertility

NCT03109964 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.

NCT NCT03109964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03109964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Affect of Hemostasis With Bipolar Coagulation Versus SURGIFLO Placement on Ovarian Reserve and Future Fertility
Lead sponsor
Rambam Health Care Campus
Phase
Not applicable
Overall status
Completed
Start date
November 20, 2018
Completion date
August 1, 2022
Enrollment
127 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cyst ovary